Treatment Of Neurological Diseases In Cardiac Patients

The increasing comorbidity of cardiological and neurological diseases is mainly based on vascular processes with ischemic damage of the brain or heart tissue. They require a highly specialised acute treatment (Chest/Stroke Unit). Secondary prevention is often identical except of stroke prevention by anticoagulation in cardiac disease (e.g. AF). Long QTc syndromes caused by interaction of neuro-psychiatric drugs are frequent and underestimated with regard to their impact. Neuropsychological deficits are underdiagnosed in cardiac patients especially after CRP and multiple (silent) strokes.